The Partnership for Increasing the Impact of Vector Control brings together researchers and policy makers to stimulate the vector control research pipeline. We are investing in promising future leaders of vector-borne disease research, filling knowledge gaps, and ensuring the sustainable use of evidence in decision-making at all levels.
Vector-borne diseases such as malaria, dengue and sleeping sickness are pervasive, causing massive morbidity and mortality and severely retarding economic development across the developing world. Many of our current tools are inadequate, outdated, or failing due to insecticide resistance. The evidence base for newer interventions remains weak. Despite this, there is a critical shortage of researchers developing and evaluating innovative new approaches to control these diseases and a severe lack of the recognition of the pivotal role of vector control in breaking disease transmission and reaching elimination targets at the global level.
Through funding from the UK Research and Innovation Global Challenges Research Fund (GCRF), we have established a Partnership for Increasing the Impact of Vector Control (PIIVeC) to address this problem. We are bringing together leading research institutes and national disease control programmes from three African countries with exceptionally high burdens of vector-borne disease, Burkina Faso, Cameroon and Malawi, to develop evidence-based solutions for integrated vector control. Supported by long term mentorship from LSTM and rigorous evaluation of the capacity needs in-country, the Partnership will generate new knowledge and tools, strengthen research capacity, and reinforce links between researchers and policy-makers, leading to reduced disease burden and increased resilience for responding to outbreaks.